Cellectar Biosciences Inc.

CLRB | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.31

-$0.04 (-1.70%)

Sep 22, 2026, 11:20 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-21.79M	-44.58M	-42.77M	-28.6M	-24.12M	-15.09M
Depreciation & Amortization	213.6K	291.65K	192.38K	148.44K	149.92K	141.45K
Stock-Based Compensation	2.26M	4.27M	2.41M	1.45M	1.12M	467.54K
Other Working Capital	34.82K	-132.42K	3.48M	1.68M	198.76K	671.24K
Other Non-Cash Items	-677.51K	-5.84M	4.32M	93.82K	80.66K	-118.8K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-3.13M	-1.73M	3.48M	1.68M	198.76K	671.24K
Operating Cash Flow	-23.12M	-47.58M	-32.38M	-25.22M	-22.57M	-13.93M
Capital Expenditures	-5.88K	-104.2K	-864.04K	-225.97K	-141.36K	-62.35K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-5.88K	-104.2K	-864.04K	-225.97K	-141.36K	-62.35K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	184K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	789.64K	-9.61M	1.21M	642.5K
Financial Cash Flow	13.03M	61.41M	22.94M	9.61M	1.25M	60.55M
Net Cash Flow	-10.09M	13.72M	-10.3M	-15.84M	-21.46M	46.55M
Free Cash Flow	-23.12M	-47.69M	-33.24M	-25.45M	-22.71M	-14M
Adj. Free Cash Flow	-25.39M	-51.96M	-35.65M	-26.9M	-23.83M	-14.46M
Maintenance CapEx	-5.88K	-104.2K	-192.38K	-148.44K	-141.36K	-62.35K
Growth CapEx	n/a	n/a	-671.66K	-77.54K	n/a	n/a
Owner Earnings	-23.12M	-47.69M	-32.57M	-25.37M	-22.71M	-14M